Table 2.
Baseline level and trend in monthly number of dispensings (DISP)* per 100 000 for OH and AH medicines, and changes in level and trend by stage of the ‘FP’ programme, Brazil, 2008–2012
| Baseline | AFP-II (Apr 2009) | SNP (Feb 2011) | ||||||||
| Level (DISP) |
Trend | DISP (Mar 2009) |
Level AFP-II (Apr 2009) | Trend AFP-II |
% Relative change (AFP-II) (Apr 2010) |
DISP (Jan 2011) | Level SNP (Feb 2011) |
Trend SNP |
% Relative change (SNP) (Feb 2012) |
|
| OH | 2.45 | 0.16 | 4.85 | −2.12 (−3.13;−1.1) | −0.15 (−0.24;−0.06) | −54.5 | 3.23 | 4.39 (3.47;5.31) | 0.40 (0.33;0.47) | 262.0 |
| Glibenclamide 5 mg | 0.58 | 0.04 | 1.25 | −0.67 (−0.99;−0.35) | −0.05 (−0.07;−0.02) | −63.7 | 0.66 | 1.22 (0.93;1.52) | 0.10(0.07;0.12) | 350.2 |
| Metformin 850 mg | 1.14 | 0.07 | 2.19 | −1.01 (−1.43;−0.59) | −0.06 (−0.1;−0.03) | −55.4 | 1.43 | 1.98 (1.6;2.36) | 0.15 (0.12;0.18) | 239.8 |
| Metformin 500 mg | 0.51 | 0.02 | 0.73 | −0.26 (−0.48;−0.05) | −0.02 (−0.04;0.00) | −48.7 | 0.46 | 0.68 (0.48;0.88) | 0.04 (0.03;0.06) | 258.9 |
| Metformin slow release | 0.23 | 0.03 | 0.67 | −0.16 (−0.38;0.06) | −0.02 (−0.04;0.00) | −39.2 | 0.69 | 0.47 (0.27;0.66) | 0.12 (0.1;0.13) | 226.5 |
| Oral AH | 6.94 | 0.51 | 14.58 | −7.28 (−12.1;−2.45) | −0.5 (−0.93;−0.06) | −60.1 | 8.56 | 15.91 (11.45;20.37) | 1.5 (1.16;1.84) | 371.9 |
| Atenolol 25 mg | 1.59 | 0.09 | 2.90 | −1.1 (−1.68;−0.52) | −0.1 (−0.15;−0.04) | −53.3 | 1.81 | 1.87 (1.34;2.4) | 0.21 (0.17;0.25) | 242.4 |
| Propranolol 40 mg | 0.45 | 0.04 | 1.03 | −0.64 (−0.99;−0.29) | −0.04 (−0.07;−0.01) | −72.8 | 0.37 | 0.76 (0.43;1.1) | 0.05 (0.03;0.07) | 424.7 |
| Hydrochlorothiazide 25 mg | 1.31 | 0.14 | 3.46 | −2.05 (−3.14;−0.97) | −0.14 (−0.24;−0.04) | −67.6 | 1.75 | 4.15 (3.16;5.14) | 0.4 (0.33;0.48) | 481.1 |
| Captopril 25 mg | 1.42 | 0.11 | 3.12 | −1.8 (−2.42;−1.17) | −0.13 (−0.18;−0.07) | −69.3 | 1.29 | 1.92 (1.34;2.51) | 0.08 (0.03;0.12) | 244.3 |
| Enalapril 5 mg | 2.18 | 0.12 | 4.04 | −1.42 (−2.04;−0.8) | −0.13(−0.18;−0.07) | −50.0 | 2.78 | 1.93 (1.36;2.5) | 0.13 (0.09;0.17) | 123.1 |
Significant values p<0.05 are highlighted in bold.
*DISP is number of dispensings. The number of dispensings was divided by 100 000.
AFP-II, Aqui tem Farmácia Popular II; AH, antihypertensive; FP, Farmácia Popular; NA, no applicable; OH, oral hypoglycaemic; PDC, proportion of days covered; SNP, Saúde Não Tem Preço.